Search Clinical Trials
583,695 trials
ID
Status
Phase
Title
Sponsor
NCT07575191
Safety and Performance of a Novel Infusion Catheter System for Peri/Intratumoral Gemcitabine Delivery in Patients With Pancreatic CancerSmartwise Sweden ABNot Yet RecruitingPhase 1
NCT07575191Not Yet Recruiting
Phase 1
Safety and Performance of a Novel Infusion Catheter System for Peri/Intratumoral...Smartwise Sweden AB
NCT07576881
Impact of Standardization on Outcomes Following Cervical RipeningIndiana UniversityNot Yet RecruitingPhase 2
NCT07576881Not Yet Recruiting
Phase 2
Impact of Standardization on Outcomes Following Cervical RipeningIndiana University
NCT07575906
A Study to Learn How a Single Dose of the Study Medicine Called PF-08057418 is Tolerated in the Body of Healthy Adults.PfizerNot Yet RecruitingPhase 1
NCT07575906Not Yet Recruiting
Phase 1
A Study to Learn How a Single Dose of the Study Medicine Called PF-08057418 is T...Pfizer
NCT07576049
COLORECTAL CANCER: SINGLE CENTER EXPERIENCEUniversity of Roma La SapienzaEnrolling By Invitation
NCT07576049Enrolling By Invitation
—
COLORECTAL CANCER: SINGLE CENTER EXPERIENCEUniversity of Roma La Sap...
NCT07575243
Thyroidectomy-specific Enhanced Recovery After Surgery (ERAS) ProtocolAssiut UniversityCompleted
NCT07575243Completed
—
Thyroidectomy-specific Enhanced Recovery After Surgery (ERAS) ProtocolAssiut University
NCT07575178
Obstacle Course Versus Neuromotor Task Training in Children With DCDRiphah International UniversityNot Yet RecruitingNot Applicable
NCT07575178Not Yet Recruiting
Not Applicable
Obstacle Course Versus Neuromotor Task Training in Children With DCDRiphah International Univ...
NCT07575646
Clinical Evaluation of Self-Adhesive Flowable Giomer With and Without Selective Enamel EtchingCairo UniversityNot Yet RecruitingNot Applicable
NCT07575646Not Yet Recruiting
Not Applicable
Clinical Evaluation of Self-Adhesive Flowable Giomer With and Without Selective...Cairo University
NCT07574619
Improving Choice And Use Of Biomedical HIV Prevention For Women In Uganda: A Couples-based ApproachMU-JHU CARENot Yet RecruitingNot Applicable
NCT07574619Not Yet Recruiting
Not Applicable
Improving Choice And Use Of Biomedical HIV Prevention For Women In Uganda: A Cou...MU-JHU CARE
NCT07575100
MAITLAND MOBILIZATION VERSUS THERAPEUTIC ULTRASOUND ON TRISMUS FOLLOWING THIRD MOLAR SURGERYCairo UniversityCompletedNot Applicable
NCT07575100Completed
Not Applicable
MAITLAND MOBILIZATION VERSUS THERAPEUTIC ULTRASOUND ON TRISMUS FOLLOWING THIRD M...Cairo University
NCT07576179
Plantar Intrinsic Muscles Exercises and Three-dimensional Ankle Foot Exercises Comparative Effect in DPNRiphah International UniversityRecruitingNot Applicable
NCT07576179Recruiting
Not Applicable
Plantar Intrinsic Muscles Exercises and Three-dimensional Ankle Foot Exercises C...Riphah International Univ...
NCT07574957
Prediction of Peritoneal Dissemination of Digestive Tumors Through the Study of Circulating Tumor DNAAssistance Publique - Hôpitaux de ParisNot Yet Recruiting
NCT07574957Not Yet Recruiting
—
Prediction of Peritoneal Dissemination of Digestive Tumors Through the Study of...Assistance Publique - Hôp...
NCT07576608
A Phase II Study of 9MW3811 in Patients With Pathological ScarMabwell (Shanghai) Bioscience Co., Ltd.RecruitingPhase 2
NCT07576608Recruiting
Phase 2
A Phase II Study of 9MW3811 in Patients With Pathological ScarMabwell (Shanghai) Biosci...
NCT07575113
Comparison of Otago and Beat it Program on Balance, Gait and QOL in Diabetic NeuropathyRiphah International UniversityNot Yet RecruitingNot Applicable
NCT07575113Not Yet Recruiting
Not Applicable
Comparison of Otago and Beat it Program on Balance, Gait and QOL in Diabetic Neu...Riphah International Univ...
NCT07576010
Steroids Combined With Ruxolitinib as First-Line Therapy for Grade II Acute Graft-versus-Host DiseaseDaihong LiuActive Not RecruitingPhase 1
NCT07576010Active Not Recruiting
Phase 1
Steroids Combined With Ruxolitinib as First-Line Therapy for Grade II Acute Graf...Daihong Liu
NCT07575893
CD30 CAR-T Cells for Low Risk Relapsed Classical Hodgkin LymphomaMemorial Sloan Kettering Cancer CenterNot Yet RecruitingPhase 1
NCT07575893Not Yet Recruiting
Phase 1
CD30 CAR-T Cells for Low Risk Relapsed Classical Hodgkin LymphomaMemorial Sloan Kettering...
NCT07576374
Specificities of Atypical Non AutoImmune Diabetes (ANAID) in the French West IndiesCentre Hospitalier Universitaire de la GuadeloupeNot Yet Recruiting
NCT07576374Not Yet Recruiting
—
Specificities of Atypical Non AutoImmune Diabetes (ANAID) in the French West Ind...Centre Hospitalier Univer...
NCT07576842
Testing the Feasibility of Different HPV Screening and Care Strategies for Women Living With HIVBeth Israel Deaconess Medical CenterNot Yet RecruitingNot Applicable
NCT07576842Not Yet Recruiting
Not Applicable
Testing the Feasibility of Different HPV Screening and Care Strategies for Women...Beth Israel Deaconess Med...
NCT07574658
Brief Cognitive Behavioral Therapy for Suicide Prevention in a Brazilian Sample: a Study Protocol of a Randomized Clinical TrialUniversity of Sao PauloNot Yet RecruitingPhase 3
NCT07574658Not Yet Recruiting
Phase 3
Brief Cognitive Behavioral Therapy for Suicide Prevention in a Brazilian Sample:...University of Sao Paulo
NCT07576543
Long-term Follow-up of Dexmedetomidine-esketamine and tDCS for Neurocognitive Complications After SurgeryFujian Medical University Union HospitalNot Yet RecruitingPhase 4
NCT07576543Not Yet Recruiting
Phase 4
Long-term Follow-up of Dexmedetomidine-esketamine and tDCS for Neurocognitive Co...Fujian Medical University...
NCT07575568
Revascularization With Modification Using Definitive IVL and Serration Remodeling for Optimal LumenAustralian Healthcare SolutionsNot Yet RecruitingNot Applicable
NCT07575568Not Yet Recruiting
Not Applicable
Revascularization With Modification Using Definitive IVL and Serration Remodelin...Australian Healthcare Sol...
Result Breakdown
Not yet recruiting14 (70%)
Completed2 (10%)
Recruiting2 (10%)
Enrolling by invitation1 (5%)
Active, not recruiting1 (5%)
not_applicable8 (40%)
Phase 14 (20%)
Not Specified4 (20%)
Phase 22 (10%)
Phase 31 (5%)
Phase 41 (5%)